DRUG
Price
$34.01
Change
-$1.45 (-4.09%)
Updated
Jul 28, 04:57 PM (EDT)
Capitalization
240.78M
MNMD
Price
$9.68
Change
-$0.08 (-0.82%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
731.36M
2 days until earnings call
Interact to see
Advertisement

DRUG vs MNMD

Header iconDRUG vs MNMD Comparison
Open Charts DRUG vs MNMDBanner chart's image
Bright Minds Biosciences
Price$34.01
Change-$1.45 (-4.09%)
Volume$100
Capitalization240.78M
Mind Medicine (MindMed)
Price$9.68
Change-$0.08 (-0.82%)
Volume$20.78K
Capitalization731.36M
DRUG vs MNMD Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. MNMD commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a StrongBuy and MNMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (DRUG: $33.86 vs. MNMD: $9.68)
Brand notoriety: DRUG and MNMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 194% vs. MNMD: 66%
Market capitalization -- DRUG: $240.78M vs. MNMD: $731.36M
DRUG [@Biotechnology] is valued at $240.78M. MNMD’s [@Biotechnology] market capitalization is $731.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileMNMD’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • MNMD’s FA Score: 0 green, 5 red.
According to our system of comparison, MNMD is a better buy in the long-term than DRUG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 4 TA indicator(s) are bullish while MNMD’s TA Score has 7 bullish TA indicator(s).

  • DRUG’s TA Score: 4 bullish, 5 bearish.
  • MNMD’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, MNMD is a better buy in the short-term than DRUG.

Price Growth

DRUG (@Biotechnology) experienced а +29.53% price change this week, while MNMD (@Biotechnology) price change was -2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was +17.90%, and the average quarterly price growth was +45.83%.

Reported Earning Dates

DRUG is expected to report earnings on May 15, 2025.

MNMD is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNMD($731M) has a higher market cap than DRUG($241M). MNMD YTD gains are higher at: 39.080 vs. DRUG (-5.997). DRUG has higher annual earnings (EBITDA): -2.67M vs. MNMD (-75.18M). MNMD has more cash in the bank: 212M vs. DRUG (57.9M). DRUG has less debt than MNMD: DRUG (183K) vs MNMD (22M). DRUG (0) and MNMD (0) have equivalent revenues.
DRUGMNMDDRUG / MNMD
Capitalization241M731M33%
EBITDA-2.67M-75.18M4%
Gain YTD-5.99739.080-15%
P/E RatioN/AN/A-
Revenue00-
Total Cash57.9M212M27%
Total Debt183K22M1%
FUNDAMENTALS RATINGS
MNMD: Fundamental Ratings
MNMD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRUGMNMD
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 29 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYSOX96.61N/A
N/A
Rydex S&P 500 A
ASERX118.50N/A
N/A
American Century Select R
NVSCX31.98N/A
N/A
Allspring Small Company Growth Admin
MUESX35.76N/A
N/A
MFS Blended Research Core Equity R2
CUSCX11.53-0.13
-1.11%
Cullen Small Cap Value C

MNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNMD has been loosely correlated with ATAI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MNMD jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNMD
1D Price
Change %
MNMD100%
-0.82%
ATAI - MNMD
53%
Loosely correlated
-6.72%
BEAM - MNMD
51%
Loosely correlated
-4.10%
RXRX - MNMD
51%
Loosely correlated
-2.77%
OCUL - MNMD
51%
Loosely correlated
-1.06%
EYPT - MNMD
50%
Loosely correlated
-4.29%
More